Tanios Bekaii-Saab, MD: Strategies to Increase RAS Testing
What strategies can be used to increase the percentage of patients who receive recommended RAS testing?
There are a number of ways to do this. One is to increase the level of education for pathologists for pathologists, as well as gastroenterologists and surgeons. So the folks who see the patients first before they send them to an oncologist, they need to know about the importance of this test. It should be more automatically thought of than it is today.
Unresectable Colon Cancer: Case 2
52-year-old woman newly diagnosed with metastatic CRC and is genotyped as part of her initial work up.
Phase 3 Trials of Botensilimab/Balstilimab Move Forward, Despite FDA's Approval Setback
July 18th 2024Agenus was advised by the FDA against filing for accelerated approval of botensilimab plus balstilimab for relapsed/refractory microsatellite stable metastatic colorectal cancer without liver metastases.
Read More
